Buhlmann S, Racek T, John K, Schaefer S, Pützer BM.
Differential regulation of hepatitis B virus core promoter/enhancer II by TAp73 and its oncogenic counterpart DNp73: implications for hepatocarcinogenesis.
Hepatology Intl. 2008; 2(2): S42 PL-02.
2008
Previous Post
Molecular mechanisms of hepatocarcinogenesis in DNp73-Transgenic mice: significance of N-Terminally truncated p73 Species for liver cancer therapy.
Next Post
Selective Targeting of Adenoviral Vectors to Neural Precursor Cells in the Hippocampus of Adult Mice: New Prospects for In Situ Gene Therapy.

Contact
Institute of Experimental Gene Therapy and Cancer Research
Core-Facility Viral Vector & Genome-Editing Technologies
Biomedical Research Center
Schillingallee 69
D-18057 Rostock
Office
Ingrid Winkler
(+49) 381 494-5066(+49) 381 494-5062
ingrid.winkler@med.uni-rostock.de
Department Life, Light & Matter
Research Building LL&M
Albert-Einstein-Str. 25
D-18059 Rostock
Research Building LL&M
Albert-Einstein-Str. 25
D-18059 Rostock